EUVIMEDEUVIMED entdecken
Crossref

Lymph node metastasis and treatment outcomes of endoscopic submucosal dissection for superficial spreading esophageal squamous cell carcinoma ≥ 50 mm in size

Satoshi Masuda, Yuji Urabe iD, Yoshiki Hatsushika, Takahiro Uda, Yukiko Sako, Tomoyuki Gurita, Takeo Nakamura, Hirona Konishi, Kazuki Ishibashi, Takeshi Takasago, Hidenori Tanaka, Akiyoshi Tsuboi und 7 weitere

Esophagus · 2025

DOI: 10.1007/s10388-025-01136-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Esophagus, 2025. Verfasst von Satoshi Masuda und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hiroshima University Hospital, 1-2-3, Kasumi, Minamiku, Hiroshima, 734-8551, Japan. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Esophageal Neoplasms, Lymphatic Metastasis, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The precise indications for endoscopic submucosal dissection (ESD) in superficial spreading esophageal squamous cell carcinoma (SESCC) remain unclear. This study aimed to evaluate the lymph node metastasis rates and outcomes of ESD for SESCC lesions ≥ 50 mm, focusing on diagnostic accuracy, short-term outcomes, and long-term prognoses. METHODS: We retrospectively analyzed 79 patients who underwent ESD for SESCC between January 2011 and December 2018. We assessed lymph node metastasis rates, diagnostic accuracy, short-term outcomes, and long-term survival rates. RESULTS: The en bloc resection and R0 resection rates were 98.7% and 94.9%, respectively. The diagnostic accuracy for tumor invasion depth was 74.7%. Lymph node metastasis occurred in 7.6% of patients, contributing to four primary cancer-related deaths (3.8%). Postoperative esophageal stenosis occurred in 65.6% of whole-circumference cases, with refractory stenosis requiring > 5 endoscopic balloon dilation procedures in 87.5% of affected patients. Overall survival (OS) rates were 91% at 3 years and 84% at 5 years, whereas recurrence-free survival (RFS) rates were 87% at 3 years and 80% at 5 years. CONCLUSIONS: ESD for SESCC achieves high resection success rates but is associated with significant challenges, including refractory stenosis and lymph node recurrence, particularly in pLPM and pMM cases. Enhanced diagnostic and surveillance protocols, along with novel strategies for stenosis prevention, are necessary to improve outcomes and patient quality of life. Further comparative studies with surgical and chemoradiotherapy modalities are also needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionEsophageal NeoplasmsLymphatic MetastasisEsophageal Squamous Cell CarcinomaHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomeSurvival RateEsophageal StenosisAged, 80 and overPostoperative ComplicationsNeoplasm InvasivenessPrognosis

Stichwörter der Autor:innen

Endoscopic submucosal dissectionLymph node metastasisSuperficial spreading esophageal squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Gastroenterology, Hiroshima University Hospital, 1-2-3, Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Department of Gastroenterology, Hiroshima University Hospital, 1-2-3, Kasumi, Minamiku, Hiroshima, 734-8551, Japan. beyan13@hiroshima-u.ac.jp.
  • Department of Clinical Research Center, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Gastrointestinal Endoscopy and Medicine, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Yuji Urabe

Zitieren

APA

Masuda, S., Urabe, Y., Hatsushika, Y., Uda, T., Sako, Y., Gurita, T., Nakamura, T., Konishi, H., Ishibashi, K., Takasago, T., Tanaka, H., Tsuboi, A., Yamashita, K., Hiyama, Y., Kishida, Y., Takigawa, H., Ishikawa, A., Kuwai, T., & Oka, S. (2025). Lymph node metastasis and treatment outcomes of endoscopic submucosal dissection for superficial spreading esophageal squamous cell carcinoma ≥ 50 mm in size. Esophagus. https://doi.org/10.1007/s10388-025-01136-5

Vancouver

Masuda S, Urabe Y, Hatsushika Y, Uda T, Sako Y, Gurita T, et al. Lymph node metastasis and treatment outcomes of endoscopic submucosal dissection for superficial spreading esophageal squamous cell carcinoma ≥ 50 mm in size. Esophagus. 2025. doi:10.1007/s10388-025-01136-5

BibTeX
@article{Masuda2025,
  author = {Masuda, Satoshi and Urabe, Yuji and Hatsushika, Yoshiki and Uda, Takahiro and Sako, Yukiko and Gurita, Tomoyuki and Nakamura, Takeo and Konishi, Hirona and Ishibashi, Kazuki and Takasago, Takeshi and Tanaka, Hidenori and Tsuboi, Akiyoshi and Yamashita, Ken and Hiyama, Yuichi and Kishida, Yoshihiro and Takigawa, Hidehiko and Ishikawa, Akira and Kuwai, Toshio and Oka, Shiro},
  title = {Lymph node metastasis and treatment outcomes of endoscopic submucosal dissection for superficial spreading esophageal squamous cell carcinoma ≥ 50 mm in size},
  journal = {Esophagus},
  year = {2025},
  doi = {10.1007/s10388-025-01136-5}
}
Kostenlos starten →